Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Amortizatization of Intangibles (2020 - 2022)

Palisade Bio has reported Amortizatization of Intangibles over the past 3 years, most recently at -$2.3 million for Q4 2022.

  • Quarterly Amortizatization of Intangibles changed N/A to -$2.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Dec 2022, changed N/A year-over-year, with the annual reading at $2.3 million for FY2021, 1057.92% up from the prior year.
  • Amortizatization of Intangibles was -$2.3 million for Q4 2022 at Palisade Bio, down from $131000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $1.6 million in Q1 2021 and troughed at -$2.3 million in Q4 2022.
  • The 3-year median for Amortizatization of Intangibles is $150500.0 (2020), against an average of $31666.7.
  • The largest YoY upside for Amortizatization of Intangibles was 555.0% in 2021 against a maximum downside of 555.0% in 2021.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $170000.0 in 2020, then dropped by 22.94% to $131000.0 in 2021, then tumbled by 1881.68% to -$2.3 million in 2022.
  • Per Business Quant, the three most recent readings for PALI's Amortizatization of Intangibles are -$2.3 million (Q4 2022), $131000.0 (Q3 2021), and $613000.0 (Q2 2021).